Clinical trials for Cancer in United States

A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)

Study ID: NCT05568420

Sponsor

Memorial Sloan Kettering Cancer Center

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Study ID: NCT06291220

Sponsor

AbbVie

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Study ID: NCT06319820

Sponsor

Janssen Research & Development, LLC

Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Study ID: NCT06625320

Sponsor

Revolution Medicines, Inc.

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

Study ID: NCT06117774

Sponsor

Amgen

Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems

Study ID: NCT06843720

Sponsor

M.D. Anderson Cancer Center

Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Study ID: NCT06817720

Sponsor

M.D. Anderson Cancer Center

PD-L1 T-haNK, N-803 IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC

Study ID: NCT06239220

Sponsor

Glenn J. Hanna

Impact of Protect Your Colon™ on CRC Screening

Study ID: NCT05929820

Sponsor

Cedars-Sinai Medical Center

DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)

Study ID: NCT04567420

Sponsor

Criterium, Inc.